Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Lupus
|
May 13, 2009
Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
S Dolff, W H Abdulahad, M Bijl, et al.
Nephron. Clinical Practice
|
November 18, 2014
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatment
J S F Sanders, W H Abdulahad, C A Stegeman, et al.
Kidney International
|
July 14, 2006
Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis
W H Abdulahad, Y M van der Geld, C A Stegeman, et al.
Journal of Autoimmunity
|
May 1, 2024
Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity
C G Bonasia, N Inrueangsri, T Bijma, et al.
Arthritis and Rheumatism
|
January 13, 2011
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study
W H Abdulahad, J M Meijer, F G M Kroese, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
August 6, 2014
Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection
W B van Doesum, W H Abdulahad, M C R F van Dijk, et al.
Clinical and Experimental Immunology
|
July 24, 2014
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
A W S de Souza, W H Abdulahad, P Sosicka, et al.
Rheumatology (Oxford, England)
|
April 6, 2007
Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis
E R Popa, C A Stegeman, W H Abdulahad, et al.
Annals of the Rheumatic Diseases
|
January 30, 2014
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
P M Meiners, A Vissink, F G M Kroese, et al.
Annals of the Rheumatic Diseases
|
July 19, 2013
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome
R P E Pollard, W H Abdulahad, H Bootsma, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Lupus
|
May 13, 2009
Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
S Dolff, W H Abdulahad, M Bijl, et al.
Nephron. Clinical Practice
|
November 18, 2014
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatment
J S F Sanders, W H Abdulahad, C A Stegeman, et al.
Kidney International
|
July 14, 2006
Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis
W H Abdulahad, Y M van der Geld, C A Stegeman, et al.
Journal of Autoimmunity
|
May 1, 2024
Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity
C G Bonasia, N Inrueangsri, T Bijma, et al.
Arthritis and Rheumatism
|
January 13, 2011
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study
W H Abdulahad, J M Meijer, F G M Kroese, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
August 6, 2014
Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection
W B van Doesum, W H Abdulahad, M C R F van Dijk, et al.
Clinical and Experimental Immunology
|
July 24, 2014
Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
A W S de Souza, W H Abdulahad, P Sosicka, et al.
Rheumatology (Oxford, England)
|
April 6, 2007
Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis
E R Popa, C A Stegeman, W H Abdulahad, et al.
Annals of the Rheumatic Diseases
|
January 30, 2014
Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
P M Meiners, A Vissink, F G M Kroese, et al.
Annals of the Rheumatic Diseases
|
July 19, 2013
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjogren's syndrome
R P E Pollard, W H Abdulahad, H Bootsma, et al.
Page
of 1